These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2812040)

  • 21. Endothelial thromboxane production plays a role in the contraction caused by 5-hydroxytryptamine in rat basilar arteries.
    Descombes JJ; Devys M; Laubie M; Verbeuren TJ
    Eur J Pharmacol; 1993 Oct; 243(2):193-9. PubMed ID: 8276069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vasomotor effects of 5-hydroxytryptamine on equine basilar arteries in vitro.
    Miyamoto A; Obi T; Nishio A
    Vet Res Commun; 1996; 20(1):61-70. PubMed ID: 8693702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
    Frenken M
    J Pharmacol Exp Ther; 1989 Jul; 250(1):379-87. PubMed ID: 2545865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
    Müller-Schweinitzer E; Neumann P
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
    Zhang H; Stockbridge N; Weir B
    Adv Exp Med Biol; 1991; 304():531-41. PubMed ID: 1839488
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasodilator action of cromakalim on human mesenteric artery.
    McDonald A; MacDonald E; Wadsworth RM; Scott PJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):303-5. PubMed ID: 8243545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of K+ channels in neuropeptide Y-induced vasoconstriction in rabbit cerebral basilar artery.
    Xia Y; Han C
    Eur J Pharmacol; 1994 Apr; 255(1-3):67-72. PubMed ID: 8026555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasorelaxing effect in rat thoracic aorta caused by fraxinellone and dictamine isolated from the Chinese herb Dictamnus dasycarpus Turcz: comparison with cromakalim and Ca2+ channel blockers.
    Yu SM; Ko FN; Su MJ; Wu TS; Wang ML; Huang TF; Teng CM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):349-55. PubMed ID: 1377790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle.
    Deitmer P; Golenhofen K; Noack T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
    Stockbridge N; Zhang H; Weir B
    Biochem Biophys Res Commun; 1991 Nov; 181(1):172-8. PubMed ID: 1958186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium efflux enhancement by cromakalim (BRL 34915) in rabbit mesenteric artery: an indirect effect independent of calcium?
    Coldwell MC; Howlett DR
    Biochem Pharmacol; 1988 Nov; 37(21):4105-10. PubMed ID: 3190749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mechanism of the potent vasoconstrictor responses to ryanodine in dog cerebral arteries.
    Asano M; Kuwako M; Nomura Y; Suzuki Y; Shibuya M; Sugita K; Ito K
    Eur J Pharmacol; 1996 Sep; 311(1):53-60. PubMed ID: 8884236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of cytochrome P-450 inhibitors on endothelium-dependent nitro-L-arginine-resistant relaxation and cromakalim-induced relaxation in rat mesenteric arteries.
    Van de Voorde J; Vanheel B
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):827-32. PubMed ID: 9234666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of 5-hydroxytryptamine receptors on the isolated pig basilar artery by functional and radioligand binding studies.
    Miyamoto A; Sakota T; Nishio A
    Jpn J Pharmacol; 1994 Jul; 65(3):265-73. PubMed ID: 7799527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
    Cook NS; Weir SW; Danzeisen MC
    Br J Pharmacol; 1988 Nov; 95(3):741-52. PubMed ID: 2974739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cromakalim inhibits contractions of the rat isolated mesenteric bed induced by noradrenaline but not caffeine in Ca(2+)-free medium: evidence for interference with receptor-mediated Ca2+ mobilization.
    Quast U; Baumlin Y
    Eur J Pharmacol; 1991 Aug; 200(2-3):239-49. PubMed ID: 1782988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromromakalim.
    McPherson GA; Angus JA
    Br J Pharmacol; 1989 Jul; 97(3):941-9. PubMed ID: 2758244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.